Jakić-Razumović J - Search Results

1

[The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].

Jakić-Razumović J, Corić M, Vrbanec D, Babić D, Hlupić L, Belev B. Jakić-Razumović J, et al. Lijec Vjesn. 2005 Jan-Feb;127(1-2):3-7. Lijec Vjesn. 2005. PMID: 16145866 Croatian.

2

Prognostic value of different factors in breast carcinoma.

Hlupić L, Jakić-Razumović J, Bozikov J, Corić M, Belev B, Vrbanec D. Hlupić L, et al. Tumori. 2004 Jan-Feb;90(1):112-9. doi: 10.1177/030089160409000123. Tumori. 2004. PMID: 15143983

3

[Prognostic significance of newly formed blood vessels in the tumors of patients with breast cancer].

Jakić-Razumović J, Blazicević V, Uzarević B, Petrovecki M. Jakić-Razumović J, et al. Lijec Vjesn. 2002 May;124(5):123-8. Lijec Vjesn. 2002. PMID: 12152410 Croatian.

4

Nm23 gene product expression in invasive breast cancer--immunohistochemical analysis and clinicopathological correlation.

Belev B, Alerić I, Vrbanec D, Petrovecki M, Unusic J, Jakić-Razumović J. Belev B, et al. Acta Oncol. 2002;41(4):355-61. doi: 10.1080/028418602760169406. Acta Oncol. 2002. PMID: 12234027

5

[Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic neuroendocrine tumors].

Rustemović N, Berković MC, Zjacić-Rotkvić V, Ostojić R, Hrabar D, Sertić J, Jakić-Razumović J, Kruslin B, Stern-Padovan R, Tezak S, Kovacić K, Vrbanec D, Belev B, Skegro M. Rustemović N, et al. Lijec Vjesn. 2010 May-Jun;132(5-6):127-33. Lijec Vjesn. 2010. PMID: 20677617 Croatian.

6

[Consensus guidelines for diagnosis, treatment and follow-up of patients with gastrointestinal stromal tumors].

Rustemović N, Jakić-Razumović J, Belev B, Petricević B, Skegro M, Kinda E, Augustin G, Hrstić I, Ostojić R, Stern-Padovan R, Vrbanec D. Rustemović N, et al. Lijec Vjesn. 2011 May-Jun;133(5-6):170-6. Lijec Vjesn. 2011. PMID: 21888081 Review. Croatian.

7

Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study.

Jelisavac-Cosic S, Sirotkovic-Skerlev M, Kulic A, Jakic-Razumovic J, Kovac Z, Vrbanec D. Jelisavac-Cosic S, et al. Tumori. 2011 Jul-Aug;97(4):532-9. doi: 10.1177/030089161109700419. Tumori. 2011. PMID: 21989445

8

[Breast cancer metastases to the stomach and colon: two case reports].

Pulanić R, Jelavić M, Premuzić M, Opacić M, Jakic-Razumović J, Padovan-Stern R, Vrbanec D. Pulanić R, et al. Lijec Vjesn. 2012 May-Jun;134(5-6):159-63. Lijec Vjesn. 2012. PMID: 22930934 Croatian.

9

Prognostic value of proliferation markers expression in breast cancer.

Dedić Plavetić N, Jakić-Razumović J, Kulić A, Vrbanec D. Dedić Plavetić N, et al. Med Oncol. 2013 Jun;30(2):523. doi: 10.1007/s12032-013-0523-x. Epub 2013 Mar 7. Med Oncol. 2013. PMID: 23468220

10

Prognostic value of ki-67 in breast carcinoma: tissue microarray method versus whole section analysis- potentials and pitfalls.

Dedić Plavetić N, Jakić-Razumović J, Kulić A, Sirotković-Skerlev M, Barić M, Vrbanec D. Dedić Plavetić N, et al. Pathol Oncol Res. 2015 Apr;21(2):315-24. doi: 10.1007/s12253-014-9823-5. Epub 2014 Aug 6. Pathol Oncol Res. 2015. PMID: 25096394 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters